INCYTE CORPORATION Share-based Payment Arrangement, Expense
INCYTE CORPORATION (INCY) reported Share-based Payment Arrangement, Expense of $64.10 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-04-28
- INCYTE CORPORATION share-based payment arrangement, expense for the quarter ending 2026-03-31 was $64.10M, a 5.08% increase year-over-year.
- INCYTE CORPORATION share-based payment arrangement, expense for the quarter ending 2025-12-31 was $62.10M, a 13.51% decline year-over-year.
- INCYTE CORPORATION share-based payment arrangement, expense for the quarter ending 2025-09-30 was $61.60M, a 20.92% decline year-over-year.
- INCYTE CORPORATION share-based payment arrangement, expense for the quarter ending 2025-06-30 was $64.60M, a 14.13% increase year-over-year.
- INCYTE CORPORATION share-based payment arrangement, expense for fiscal 2025 was $249.30M, a 6.31% decline from fiscal 2024.
- INCYTE CORPORATION share-based payment arrangement, expense for fiscal 2024 was $266.10M, a 23.25% increase from fiscal 2023.
- INCYTE CORPORATION share-based payment arrangement, expense for fiscal 2023 was $215.90M, a 14.60% increase from fiscal 2022.
- INCYTE CORPORATION share-based payment arrangement, expense for fiscal 2022 was $188.40M, a 2.95% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $64.10M 10-Q · filed 2026-04-28 | $126.20M derived: sum of 2 quarters · filed 2026-04-28 | $187.80M derived: sum of 3 quarters · filed 2026-04-28 | $252.40M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $62.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $123.70M derived: sum of 2 quarters · filed 2026-02-10 | $188.30M derived: sum of 3 quarters · filed 2026-02-10 | $249.30M 10-K · filed 2026-02-10 |
| 2025-09-30 | $61.60M 10-Q · filed 2025-10-28 | $126.20M derived: sum of 2 quarters · filed 2025-10-28 | $187.20M 10-Q · filed 2025-10-28 | $259.00M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $64.60M 10-Q · filed 2025-07-29 | $125.60M 10-Q · filed 2025-07-29 | $197.40M derived: sum of 3 quarters · filed 2026-04-28 | $275.30M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $61.00M 10-Q · filed 2026-04-28 | $132.80M derived: sum of 2 quarters · filed 2026-04-28 | $210.70M derived: sum of 3 quarters · filed 2026-04-28 | $267.30M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $71.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $149.70M derived: sum of 2 quarters · filed 2026-02-10 | $206.30M derived: sum of 3 quarters · filed 2026-02-10 | $266.10M 10-K · filed 2026-02-10 |
| 2024-09-30 | $77.90M 10-Q · filed 2025-10-28 | $134.50M derived: sum of 2 quarters · filed 2025-10-28 | $194.30M 10-Q · filed 2025-10-28 | $254.30M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $56.60M 10-Q · filed 2025-07-29 | $116.40M 10-Q · filed 2025-07-29 | $176.40M derived: sum of 3 quarters · filed 2026-02-10 | $224.40M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $59.80M 10-Q · filed 2025-04-29 | $119.80M derived: sum of 2 quarters · filed 2026-02-10 | $167.80M derived: sum of 3 quarters · filed 2026-02-10 | $222.30M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $108.00M derived: sum of 2 quarters · filed 2026-02-10 | $162.50M derived: sum of 3 quarters · filed 2026-02-10 | $215.90M 10-K · filed 2026-02-10 |
| 2023-09-30 | $48.00M 10-Q · filed 2024-10-29 | $102.50M derived: sum of 2 quarters · filed 2024-10-29 | $155.90M 10-Q · filed 2024-10-29 | $208.60M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $54.50M 10-Q · filed 2024-07-30 | $107.90M 10-Q · filed 2024-07-30 | $160.60M derived: sum of 3 quarters · filed 2025-02-10 | $206.00M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $53.40M 10-Q · filed 2024-04-30 | $106.10M derived: sum of 2 quarters · filed 2025-02-10 | $151.50M derived: sum of 3 quarters · filed 2025-02-10 | $198.00M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $52.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $98.10M derived: sum of 2 quarters · filed 2025-02-10 | $144.60M derived: sum of 3 quarters · filed 2025-02-10 | $188.40M 10-K · filed 2025-02-10 |
| 2022-09-30 | $45.40M 10-Q · filed 2023-10-31 | $91.90M derived: sum of 2 quarters · filed 2023-10-31 | $135.70M 10-Q · filed 2023-10-31 | $183.90M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $46.50M 10-Q · filed 2023-08-01 | $90.30M 10-Q · filed 2023-08-01 | $138.50M derived: sum of 3 quarters · filed 2024-02-13 | $181.20M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $43.80M 10-Q · filed 2023-05-02 | $92.00M derived: sum of 2 quarters · filed 2024-02-13 | $134.70M derived: sum of 3 quarters · filed 2024-02-13 | $179.50M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $48.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $90.90M derived: sum of 2 quarters · filed 2024-02-13 | $135.70M derived: sum of 3 quarters · filed 2024-02-13 | $183.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $42.70M 10-Q · filed 2022-11-01 | $87.50M derived: sum of 2 quarters · filed 2022-11-01 | $134.80M 10-Q · filed 2022-11-01 | $180.10M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $44.80M 10-Q · filed 2022-08-02 | $92.10M 10-Q · filed 2022-08-02 | $137.40M derived: sum of 3 quarters · filed 2023-02-07 | $181.20M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $47.30M 10-Q · filed 2022-05-03 | $92.60M derived: sum of 2 quarters · filed 2023-02-07 | $136.40M derived: sum of 3 quarters · filed 2023-02-07 | $182.70M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $45.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $89.10M derived: sum of 2 quarters · filed 2023-02-07 | $135.40M derived: sum of 3 quarters · filed 2023-02-07 | $177.90M 10-K · filed 2023-02-07 |
| 2020-09-30 | $43.80M 10-Q · filed 2021-11-02 | $90.10M derived: sum of 2 quarters · filed 2021-11-02 | $132.60M 10-Q · filed 2021-11-02 | $174.60M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $46.30M 10-Q · filed 2021-08-03 | $88.80M 10-Q · filed 2021-08-03 | $130.80M derived: sum of 3 quarters · filed 2022-02-08 | $174.20M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $42.50M 10-Q · filed 2021-05-04 | $84.50M derived: sum of 2 quarters · filed 2022-02-08 | $127.90M derived: sum of 3 quarters · filed 2022-02-08 | $168.50M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $85.40M derived: sum of 2 quarters · filed 2022-02-08 | $126.00M derived: sum of 3 quarters · filed 2022-02-08 | $166.60M 10-K · filed 2022-02-08 |
| 2019-09-30 | $43.40M 10-Q · filed 2020-11-05 | $84.00M derived: sum of 2 quarters · filed 2020-11-05 | $124.60M 10-Q · filed 2020-11-05 | $162.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $40.60M 10-Q · filed 2020-08-04 | $81.20M 10-Q · filed 2020-08-04 | $118.60M derived: sum of 3 quarters · filed 2021-02-09 | $156.60M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $40.60M 10-Q · filed 2020-05-05 | $78.00M derived: sum of 2 quarters · filed 2021-02-09 | $116.00M derived: sum of 3 quarters · filed 2021-02-09 | $152.60M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $37.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $75.40M derived: sum of 2 quarters · filed 2021-02-09 | $112.00M derived: sum of 3 quarters · filed 2021-02-09 | $148.20M 10-K · filed 2021-02-09 |
| 2018-09-30 | $38.00M 10-Q · filed 2019-10-29 | $74.60M derived: sum of 2 quarters · filed 2019-10-29 | $110.80M 10-Q · filed 2019-10-29 | $144.60M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $36.60M 10-Q · filed 2019-07-30 | $72.80M 10-Q · filed 2019-07-30 | $106.60M derived: sum of 3 quarters · filed 2020-02-13 | $141.50M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $36.20M 10-Q · filed 2019-04-30 | $70.00M derived: sum of 2 quarters · filed 2020-02-13 | $104.90M derived: sum of 3 quarters · filed 2020-02-13 | $138.70M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $33.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $68.70M derived: sum of 2 quarters · filed 2020-02-13 | $102.50M derived: sum of 3 quarters · filed 2020-02-13 | $133.10M 10-K · filed 2020-02-13 |
| 2017-09-30 | $34.90M 10-Q · filed 2018-10-30 | $68.70M derived: sum of 2 quarters · filed 2018-10-30 | $99.30M 10-Q · filed 2018-10-30 | $126.90M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $33.80M 10-Q · filed 2018-07-31 | $64.40M 10-Q · filed 2018-07-31 | $92.00M derived: sum of 3 quarters · filed 2019-02-14 | $118.50M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $30.60M 10-Q · filed 2018-05-01 | $58.20M derived: sum of 2 quarters · filed 2019-02-14 | $84.70M derived: sum of 3 quarters · filed 2019-02-14 | $106.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $27.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $54.10M derived: sum of 2 quarters · filed 2019-02-14 | $75.40M derived: sum of 3 quarters · filed 2019-02-14 | $96.20M 10-K · filed 2019-02-14 |
| 2016-09-30 | $26.50M 10-Q · filed 2017-10-31 | $47.80M derived: sum of 2 quarters · filed 2017-10-31 | $68.60M 10-Q · filed 2017-10-31 | $85.70M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $21.30M 10-Q · filed 2017-08-01 | $42.10M 10-Q · filed 2017-08-01 | $59.20M derived: sum of 3 quarters · filed 2018-02-15 | $76.80M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $20.80M 10-Q · filed 2017-05-04 | $37.90M derived: sum of 2 quarters · filed 2018-02-15 | $55.50M derived: sum of 3 quarters · filed 2018-02-15 | $73.10M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $34.70M derived: sum of 2 quarters · filed 2018-02-15 | $52.30M derived: sum of 3 quarters · filed 2018-02-15 | $69.90M 10-K · filed 2018-02-15 |
| 2015-09-30 | $17.60M 10-Q · filed 2016-11-01 | $35.20M derived: sum of 2 quarters · filed 2016-11-01 | $52.80M 10-Q · filed 2016-11-01 | $68.70M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $17.60M 10-Q · filed 2016-08-09 | $35.20M 10-Q · filed 2016-08-09 | $51.10M derived: sum of 3 quarters · filed 2017-02-14 | $66.60M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $17.60M 10-Q · filed 2016-05-09 | $33.50M derived: sum of 2 quarters · filed 2017-02-14 | $49.00M derived: sum of 3 quarters · filed 2017-02-14 | $64.50M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $31.40M derived: sum of 2 quarters · filed 2017-02-14 | $46.90M derived: sum of 3 quarters · filed 2017-02-14 | $62.20M 10-K · filed 2017-02-14 |
| 2014-09-30 | $15.50M 10-Q · filed 2015-11-03 | $31.00M derived: sum of 2 quarters · filed 2015-11-03 | $46.30M 10-Q · filed 2015-11-03 | $56.10M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $15.50M 10-Q · filed 2015-08-04 | $30.80M 10-Q · filed 2015-08-04 | $40.60M derived: sum of 3 quarters · filed 2016-02-12 | $50.10M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $15.30M 10-Q · filed 2015-04-30 | $25.10M derived: sum of 2 quarters · filed 2016-02-12 | $34.60M derived: sum of 3 quarters · filed 2016-02-12 | $44.50M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $19.30M derived: sum of 2 quarters · filed 2016-02-12 | $29.20M derived: sum of 3 quarters · filed 2016-02-12 | $38.40M 10-K · filed 2016-02-12 |
| 2013-09-30 | $9.50M 10-Q · filed 2014-10-30 | $19.40M derived: sum of 2 quarters · filed 2014-10-30 | $28.60M 10-Q · filed 2014-10-30 | $37.70M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $9.90M 10-Q · filed 2014-07-31 | $19.10M 10-Q · filed 2014-07-31 | $28.20M derived: sum of 3 quarters · filed 2015-02-17 | $37.70M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $9.20M 10-Q · filed 2014-05-01 | $18.30M derived: sum of 2 quarters · filed 2015-02-17 | $27.80M derived: sum of 3 quarters · filed 2015-02-17 | $37.70M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $18.60M derived: sum of 2 quarters · filed 2015-02-17 | $28.50M derived: sum of 3 quarters · filed 2015-02-17 | $38.50M 10-K · filed 2015-02-17 |
| 2012-09-30 | $9.50M 10-Q · filed 2013-10-31 | $19.40M derived: sum of 2 quarters · filed 2013-10-31 | $29.40M 10-Q · filed 2013-10-31 | $36.80M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $9.90M 10-Q · filed 2013-08-01 | $19.80M 10-Q · filed 2013-08-01 | $27.30M derived: sum of 3 quarters · filed 2014-02-21 | $34.70M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $9.90M 10-Q · filed 2013-05-02 | $17.40M derived: sum of 2 quarters · filed 2014-02-21 | $24.80M derived: sum of 3 quarters · filed 2014-02-21 | $32.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $14.90M derived: sum of 2 quarters · filed 2014-02-21 | $22.10M derived: sum of 3 quarters · filed 2014-02-21 | $29.00M 10-K · filed 2014-02-21 |
| 2011-09-30 | $7.40M 10-Q · filed 2012-11-01 | $14.60M derived: sum of 2 quarters · filed 2012-11-01 | $21.50M 10-Q · filed 2012-11-01 | $25.70M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $7.20M 10-Q · filed 2012-08-03 | $14.10M 10-Q · filed 2012-08-03 | $18.30M derived: sum of 3 quarters · filed 2013-02-21 | $22.40M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $6.90M 10-Q · filed 2012-04-26 | $11.10M derived: sum of 2 quarters · filed 2013-02-21 | $15.20M derived: sum of 3 quarters · filed 2013-02-21 | $18.80M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $8.30M derived: sum of 2 quarters · filed 2013-02-21 | $11.90M derived: sum of 3 quarters · filed 2013-02-21 | $14.90M 10-K · filed 2013-02-21 |
| 2010-09-30 | $4.10M 10-Q · filed 2011-10-27 | $7.70M derived: sum of 2 quarters · filed 2011-10-27 | $10.70M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $3.60M 10-Q · filed 2011-07-28 | $6.70M 10-Q · filed 2011-07-28 | ||
| 2009-12-31 | $10.00M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |